换一批
换一批
作者：
Jesús Frutos,Díaz-Alejo [1]
;
Simon,April-Monn [2]
;
Marina,Cihova [3]
;
Verona,Buocikova [3]
;
Jorge,Villalón López [4]
;
Maria,Urbanova [3]
;
Carmen G,Lechuga [5]
;
Miroslav,Tomas [6]
;
Peter,Dubovan [6]
;
Bárbara Luna,Sánchez [7]
;
Sonia Camaño,Páez [7]
;
Alfonso,Sanjuanbenito [8]
;
Eduardo,Lobo [9]
;
Estefanía,Romio de la Heras [10]
;
Carmen,Guerra [11]
;
Carolina,de la Pinta [12]
;
Emma,Barreto Melian [13]
;
Mercedes,Rodríguez Garrote [13]
;
Alfredo,Carrato [14]
;
Laura,Ruiz-Cañas [15]
;
Bruno,Sainz [16]
;
Ana,Torres [7]
;
Bozena,Smolkova [3]
;
Julie,Earl [17]
作者单位：
Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS); The Biomedical Research Network in Cancer (CIBERONC); Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS); Faculty of Medicine, University of Alcalá de Henares.
[1]
Institute of Tissue Medicine and Pathology, University of Bern.
[2]
Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences.
[3]
Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS); Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS).
[4]
Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO).
[5]
Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences; Department of Surgical Oncology, National Cancer Institute, Slovak Medical University.
[6]
Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS).
[7]
The Biomedical Research Network in Cancer (CIBERONC); Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal.
[8]
Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal.
[9]
Department of Pathology, Hospital Universitario Ramón y Cajal.
[10]
The Biomedical Research Network in Cancer (CIBERONC); Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO).
[11]
Department of Radiation Oncology, Hospital Universitario Ramón y Cajal.
[12]
Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS); The Biomedical Research Network in Cancer (CIBERONC).
[13]
Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS); The Biomedical Research Network in Cancer (CIBERONC); Faculty of Medicine, University of Alcalá de Henares.
[14]
Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS); Department of Cancer, Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM); Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS.
[15]
The Biomedical Research Network in Cancer (CIBERONC); Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS); Department of Cancer, Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM); Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS.
[16]
Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS); The Biomedical Research Network in Cancer (CIBERONC); Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS); julie.earl@live.co.uk.
[17]
主题词
人类(Humans);动物(Animals);小鼠(Mice);胰腺肿瘤(Pancreatic Neoplasms);腺癌(Adenocarcinoma);生物标本库(Biological Specimen Banks);成纤维细胞(Fibroblasts);类器官(Organoids);肿瘤微环境(Tumor Microenvironment)
DOI
10.3791/65229
PMID
37306424
发布时间
2023-12-13
- 浏览0
Journal of visualized experiments
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
